339 related articles for article (PubMed ID: 20665874)
21. Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry.
Resch M; Ostheim P; Endemann DH; Debl K; Buchner S; Birner C; Maier LS; Kerber S; Luchner A; Griese DP
J Interv Cardiol; 2016 Oct; 29(5):461-468. PubMed ID: 27477024
[TBL] [Abstract][Full Text] [Related]
22. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.
Dzavík V; Buller CE; Devlin G; Carere RG; Mancini GB; Cantor WJ; Buszman PE; Rankin JM; Vozzi C; Ross JR; Forman S; Barton BA; Lamas AG; Hochman JS
Catheter Cardiovasc Interv; 2009 May; 73(6):771-9. PubMed ID: 19309733
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
[TBL] [Abstract][Full Text] [Related]
24. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
[TBL] [Abstract][Full Text] [Related]
25. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
Kandzari DE; Leon MB; Meredith I; Fajadet J; Wijns W; Mauri L
JACC Cardiovasc Interv; 2013 May; 6(5):504-12. PubMed ID: 23602459
[TBL] [Abstract][Full Text] [Related]
26. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
28. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
29. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis.
Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453
[TBL] [Abstract][Full Text] [Related]
31. Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group.
Brodie BR; Stuckey T; Downey W; Humphrey A; Nussbaum M; Laurent S; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
Catheter Cardiovasc Interv; 2008 Dec; 72(7):893-900. PubMed ID: 19016465
[TBL] [Abstract][Full Text] [Related]
32. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study.
Pleva L; Kukla P; Zapletalova J; Hlinomaz O
Catheter Cardiovasc Interv; 2018 Nov; 92(6):E416-E424. PubMed ID: 30019843
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Yoshikawa D; Hayashi M; Yasuda Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ J; 2012; 76(7):1609-15. PubMed ID: 22484980
[TBL] [Abstract][Full Text] [Related]
36. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
[TBL] [Abstract][Full Text] [Related]
37. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.
Parikh SV; Luna M; Selzer F; Marroquin OC; Mulukutla SR; Abbott JD; Holper EM
Catheter Cardiovasc Interv; 2014 Feb; 83(2):192-200. PubMed ID: 21735515
[TBL] [Abstract][Full Text] [Related]
39. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial.
Hehrlein C; Dietz U; Kubica J; Jørgensen E; Hoffmann E; Naber C; Lesiak M; Schneider H; Wiemer M; Tölg R; Richardt G
Cardiovasc Revasc Med; 2012; 13(5):260-4. PubMed ID: 22867706
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.
Bangalore S; Vlachos HA; Selzer F; Wilensky RL; Kip KE; Williams DO; Faxon DP
Catheter Cardiovasc Interv; 2011 Jan; 77(1):22-8. PubMed ID: 20506328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]